Cold Plasma Market Global Market Report 2024

Cold plasma, also known as non-thermal atmospheric pressure plasma, finds applications in various industries, including plastics and polymers, textiles, electronics, food and agriculture, and medicine. Cold plasma is a reactive gas containing ions, electrons, and neutral particles in the air, allowing the generation of ozone from oxygen molecules through electrical discharges in atmospheric gases.

The main types of cold plasma based on regime include atmospheric cold plasma and low-pressure cold plasma. Atmospheric cold plasma is ionized gas near room temperature, serving as a source of reactive species, neutral particles, electromagnetic fields, and controllable UV radiation. Cold plasma technologies encompass remote treatment, direct treatment, and electrode contact. These technologies are utilized in diverse medical applications such as wood healing, blood coagulation, dentistry, and cancer treatment. Additionally, cold plasma is employed by various end-users including the automotive, electronics and semiconductors, food processing and packaging, medical, aerospace, and polymers and plastics industries.

The cold plasma research report is one of a series of new reports that provides cold plasma statistics, including cold plasma industry global market size, regional shares, competitors with cold plasma shares, detailed cold plasma segments, market trends and opportunities, and any further data you may need to thrive in the cold plasma industry. This cold plasma research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold plasma market size has grown rapidly in recent years. It will grow from $2.73 billion in 2023 to $3.17 billion in 2024 at a compound annual growth rate (CAGR) of 16.5%. The growth observed in the historical period can be attributed to several factors, including the rise in the medical and healthcare sectors, growth in the food industry, expansion of the aviation sector, and the emergence of new markets.

The cold plasma market size is expected to see rapid growth in the next few years. It will grow to $5.96 billion in 2028 at a compound annual growth rate (CAGR) of 17.1%. The anticipated growth in the forecast period can be attributed to various factors, including the increasing demand for water and air purification, the growing electronics industry, rising research and development activities, and government support. Noteworthy trends expected in the forecast period encompass the adoption of eco-friendly and sustainable solutions, integration of nanotechnology, development of compact and portable devices, incorporation of artificial intelligence and automation, and increased collaboration within the industry.

The expanding use of cold plasma technology across diverse industries is anticipated to drive the growth of the cold plasma market. This technology is gaining popularity in medical and industrial applications, particularly in healthcare devices and diagnostics. Cold plasma is increasingly recognized for its potential in addressing various challenges, including its application as a treatment for the ongoing COVID-19 pandemic. Its ability to eliminate bacteria, especially drug-resistant strains, makes it a promising solution for preventing infections and assisting in the treatment of chronic wounds. In the textile industry, cold plasma plays a role in the hydrophilization process for treating protective clothing and sterile materials, contributing to the reduction of microorganisms. The growing global geriatric population, as reported by the World Health Organization in October 2022, underscores the increased prevalence of conditions like diabetes and chronic wounds, further propelling the cold plasma market.

The surge in infectious diseases is set to be a driving force behind the growth of the cold plasma market. Cold plasma technology's capacity to eradicate bacteria and viruses holds significant importance in healthcare settings, offering potential solutions for reducing healthcare-associated infections and contributing to air purification. A notable example is the reported increase in tuberculosis (TB) cases in the United States, according to the Centers for Disease Control and Prevention in March 2023. The rising incidence of infectious diseases, coupled with the need for effective solutions, is expected to fuel the demand for cold plasma technologies.

A prominent trend shaping the cold plasma market is the advancement of technology. Notably, in June 2021, Nordson Corporation, a US-based developer and manufacturer of dispensing equipment, introduced the MARCH MegaVIATM Plasma Treatment System. This innovative system, designed for large panels in printed circuit board manufacturing, represents a significant technological leap. With a focus on enhancing efficiency, the MegaVIATM system achieves greater panel loading with only a minimal increase in footprint. The platform's high process reproducibility and uniform plasma treatment for PCB panels showcase the ongoing trend of technological advancements in the cold plasma market.

Prominent players in the cold plasma market are actively engaged in product innovation to gain a competitive edge. In January 2021, Zayndu Ltd., a UK-based agricultural machinery manufacturing company, unveiled the Aurora Z10, incorporating an activated air seed sterilization system. This groundbreaking system provides a dry and chemical-free alternative to conventional seed treatment methods. By leveraging a unique process to generate Reactive Oxygen and Nitrogen Species (RONS) in the air, it acts as a potent disinfectant to eliminate pathogens on seeds. The technology not only enhances seed quality but also prevents soil contamination, leading to improved germination rates. The Aurora Z10's utilization of cold plasma aligns with environmentally conscious agricultural practices, positioning it as an eco-friendly and sustainable solution.

In June 2022, neoplas med GmbH, a Germany-based medical equipment manufacturing company, and Niterra Co., Ltd., a Japan-based automotive parts manufacturing company, formed a strategic partnership with a substantial investment. This collaboration is centered around neoplas med's cutting-edge therapy for chronic and infected wounds utilizing cold plasma. The kINPen MED plasma jet treatment, designed to accelerate wound healing, particularly in diabetic foot syndrome patients, boasts an impressive 59% success rate within six weeks - a substantial improvement over the 5% rate associated with standard therapy. Additionally, the treatment proves cost-effective, being up to 52% more affordable than conventional wound treatment. This significant advancement holds great promise for enhancing both wound healing outcomes and overall patient well-being.

Major companies operating in the cold plasma market market include Ethicon Inc., Baxter International Inc., 3M Company, Smith & Nephew plc., Nordson Corporation, Plasma Etch Inc., Adtech Plasma Technology Co. Ltd., P2i Limited, Relyon Plasma GmbH, Henniker Plasma Treatment, Enercon Industries Corporation, AcXys Plasma Technologies, Plasmatreat GmbH, Europlasma NV, SOFTAL Corona & Plasma GmbH, UNIQAIR Technologies Ltd., CINOGY System GmbH, neoplas med GmbH, Leaflife Technology Co. Ltd., Nova Plasma Ltd., Tantec A/S, Thierry Corporation, Surfx Technologies LLC, Coating Plasma Innovation, Ferrarini & Benelli Srl, terraplasma GmbH, Molecular Plasma Group, Advanced Plasma Solutions Co. Inc., PlasmaLeap Technologies, US Medical Innovations LLC, COMET Plasma Control Technologies

Asia-Pacific was the largest region in the cold plasma market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cold plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cold plasma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The cold plasma market consists of sales of cold plasma derived from techniques such as corona discharge and plasma jet. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.